Sibylle Uhrich

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The enzyme indoleamine 2,3-dioxygenase (IDO) is emerging as a facilitator of cancer development through its effects on cancer-associated inflammation. Recent studies report a significant improvement(More)
  • 1